MicroRNA-34a induces transdifferentiation of glioma stem cells into vascular endothelial cells by targeting Notch pathway

References

• Sampetrean O, Saya H. Characteristics of glioma stem cells. Brain Tumor Pathol. 2013;30(4):209–214.10.1007/s10014-013-0141-5
   PubMed Web of Science ®Google Scholar
• Weller M. Novel diagnostic and therapeutic approaches to malignant glioma. Swiss Med Wkly. 2011;141:w13210.
   PubMed Web of Science ®Google Scholar
• DeAngelis LM. Brain tumors. N Engl J Med. 2001;344(2):114–123.10.1056/NEJM200101113440207
   PubMed Web of Science ®Google Scholar
• Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide vs. radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459–466.10.1016/S1470-2045(09)70025-7
   PubMed Web of Science ®Google Scholar
• Grossman SA, Batara JF. Current management of glioblastoma multiforme. Semin Oncol. 2004;31(5):635–644.10.1053/j.seminoncol.2004.07.005
   PubMed Web of Science ®Google Scholar
• Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120):756–760.10.1038/nature05236
   PubMed Web of Science ®Google Scholar
• Hardee ME, Zagzag D. Mechanisms of glioma-associated neovascularization. Am J Pathol. 2012;181(4):1126–1141.10.1016/j.ajpath.2012.06.030
   PubMed Web of Science ®Google Scholar
• Jhaveri N, Chen TC, Hofman FM. Tumor vasculature and glioma stem cells: contributions to glioma progression. Cancer Lett. 2014;380(2):545–551.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Dong J, Huang Q, et al. Endothelial cell transdifferentiation of human glioma stem progenitor cells in vitro. Brain Res Bull. 2010;82(5–6):308–312.10.1016/j.brainresbull.2010.06.006
   PubMed Web of Science ®Google Scholar
• Zhu TS, Costello MA, Talsma CE, et al. Endothelial cells create a stem cell niche in glioblastoma by providing NOTCH ligands that nurture self-renewal of cancer stem-like cells. Cancer Res. 2011;71(18):6061–6072.10.1158/0008-5472.CAN-10-4269
   PubMed Web of Science ®Google Scholar
• Fuchs E, Tumbar T, Guasch G. Socializing with the neighbors: stem cells and their niche. Cell. 2004;116(6):769–778.10.1016/S0092-8674(04)00255-7
   PubMed Web of Science ®Google Scholar
• Ricci-Vitiani L, Pallini R, Biffoni M, et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature. 2010;468(7325):824–828.10.1038/nature09557
   PubMed Web of Science ®Google Scholar
• Lino MM, Merlo A, Boulay JL. Notch signaling in glioblastoma: a developmental drug target? BMC Med. 2010;8:72–80.10.1186/1741-7015-8-72
   PubMed Web of Science ®Google Scholar
• Wang J, Wakeman TP, Lathia JD, et al. Notch promotes radioresistance of glioma stem cells. Stem Cells. 2010;28(1):17–28.
   PubMed Web of Science ®Google Scholar
• Li WB, Ma MW, Dong LJ, et al. MicroRNA-34a targets notch1 and inhibits cell proliferation in glioblastoma multiforme. Cancer Biol Ther. 2011;12(6):477–483.10.4161/cbt.12.6.16300
   PubMed Web of Science ®Google Scholar
• Li JL, Harris AL. Notch signaling from tumor cells: a new mechanism of angiogenesis. Cancer Cell. 2005;8(1):1.10.1016/j.ccr.2005.06.013
   PubMed Web of Science ®Google Scholar
• Thurston G, Kitajewski J. VEGF and delta-notch: interacting signalling pathways in tumour angiogenesis. Br J Cancer. 2008;99(8):1204.10.1038/sj.bjc.6604484
   PubMed Web of Science ®Google Scholar
• Rui B, Roca C, Sörensen I, et al. The notch ligands Dll4 and jagged1 have opposing effects on angiogenesis. Cell. 2009;137(6):1124.
   PubMed Web of Science ®Google Scholar
• Segarra M, Williams CK, Sierra ML, et al. Dll4 activation of notch signaling reduces tumor vascularity and inhibits tumor growth. Blood. 2008;112(5):1904.10.1182/blood-2007-11-126045
   PubMed Web of Science ®Google Scholar
• Dufraine J, Funahashi Y, Kitajewski J. Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene. 2008;27(38):5132–5137.10.1038/onc.2008.227
   PubMed Web of Science ®Google Scholar
• Luan S, Sun L, Huang F. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Arch Med Res. 2010;41(2):67–74.10.1016/j.arcmed.2010.02.007
   PubMed Web of Science ®Google Scholar
• De Antonellis P, Medaglia C, Cusanelli E, et al. MiR-34a targeting of notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma. PLoS ONE. 2011;6(9):e24584.10.1371/journal.pone.0024584
   PubMed Web of Science ®Google Scholar
• Grosse-Gehling P, Fargeas CA, Dittfeld C, et al. CD133 as a biomarker for putative cancer stem cells in solid tumours: limitations, problems and challenges. J Pathol. 2013;229(3):355–378.10.1002/path.4086
   PubMed Web of Science ®Google Scholar
• Yu H, Shi L, Qi G, et al. Gypenoside protects cardiomyocytes against ischemia-reperfusion injury via the inhibition of mitogen-activated protein kinase mediated nuclear factor kappa B pathway in vitro and in vivo. Front Pharmacol. 2016;7:148.
   PubMed Web of Science ®Google Scholar
• Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene. 2007;26(34):5017–5022.10.1038/sj.onc.1210293
   PubMed Web of Science ®Google Scholar
• Liu C, Kelnar K, Liu B, et al. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med. 2011;17(2):211–215.10.1038/nm.2284
   PubMed Web of Science ®Google Scholar
• Nalls D, Tang SN, Rodova M, et al. Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells. PLoS ONE. 2011;6(8):e24099.10.1371/journal.pone.0024099
   PubMed Web of Science ®Google Scholar
• Wang BC, Ma J. Role of MicroRNAs in malignant glioma. Chin Med J (Engl). 2015;128(9):1238–1244.
   PubMed Web of Science ®Google Scholar
• Weeraratne SD, Amani V, Neiss A, et al. miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. Neuro-Oncology. 2011;13(2):165–175.10.1093/neuonc/noq179
   PubMed Web of Science ®Google Scholar
• Li Y, Guessous F, Zhang Y, et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009;69(19):7569–7576.10.1158/0008-5472.CAN-09-0529
   PubMed Web of Science ®Google Scholar
• Zhao T, Li J, Chen AF. MicroRNA-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metab. 2010;299(1):E110–E116.10.1152/ajpendo.00192.2010
   PubMed Web of Science ®Google Scholar
• Beier D, Hau P, Proescholdt M, et al. CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007;67(9):4010–4015.10.1158/0008-5472.CAN-06-4180
   PubMed Web of Science ®Google Scholar
• Jin X, Jin X, Jung J-E, et al. Cell surface nestin is a biomarker for glioma stem cells. Biochem Biophys Res Commun. 2013;433(4):496–501.10.1016/j.bbrc.2013.03.021
   PubMed Web of Science ®Google Scholar
• Soda Y, Hanahan D. Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci USA. 2011;108(11):4274.10.1073/pnas.1016030108
   PubMed Web of Science ®Google Scholar
• Ji Q, Hao X, Zhang M, et al. MicroRNA miR-34 inhibits human pancreatic cancer tumor-initiating cells. PLoS ONE. 2009;4(8):e6816.10.1371/journal.pone.0006816
   PubMed Web of Science ®Google Scholar
• Chen YS, Chen ZP. Vasculogenic mimicry: a novel target for glioma therapy. Chin J Cancer. 2014;33(2):74–79.10.5732/cjc.012.10292
   PubMed Web of Science ®Google Scholar